Related Experiment Video
Updated: Jun 6, 2026
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Significance of MD-2 and MD-2B expression in rat liver during acute cholangitis
Hui-Lai Miao1, Zhi-Dong Qiu, Fu-Long Hao
1Hui-Lai Miao, Zhi-Dong Qiu, Ming-Yi Li, Ming Chen, Nian-Ping Chen, Department of Hepatobiliary Surgery, the Affiliated Hospital of Guangdong Medical College, Zhanjing 524001, Guangdong Province, China.
Aim:
To investigate the expression of myeloid differentiation protein-2 (MD-2), MD-2B (a splicing isoform of MD-2 that can block Toll-like receptor 4 (TLR4)/MD-2 LPS-mediated signal transduction) and TLR4 in the liver of acute cholangitis rats.
Methods:
Male Sprague-Dawley rats (SPF level) were randomly divided into four groups: (A) sham-operated group; (B) simple common bile duct ligation group; (C) acute cholangitis group; and (D) acute cholangitis anti-TLR4 intervention group (n = 25 per group). Rat liver tissue samples were used to detect TLR4, MD-2 and MD-2B mRNA expression by fluorescence quantitative PCR in parallel with pathological changes.
Results:
In acute cholangitis, liver TLR4 and MD-2 mRNA expression levels at 6, 12, 24, 48 and 72 h were gradually up-regulated but MD-2B mRNA expression gradually down-regulated (P < 0.05). After TLR4 antibody treatment, TLR4 and MD-2 mRNA expression were lower compared with the acute cholangitis group (P < 0.05). However, MD-2B mRNA expression was higher than in the acute cholangitis group (P < 0.05). MD-2 and TLR4 mRNA expressions were positively correlated (r = 0.94981, P < 0.05) and MD-2B mRNA expression was negatively correlated with MD-2 and TLR4 mRNA (r = -0.89031, -0.88997, P < 0.05).
Conclusion:
In acute cholangitis, MD-2 plays an important role in the process of TLR4- mediated inflammatory response to liver injury while MD-2B plays a negative regulatory role.
Insights
Myeloid differentiation protein-2 (MD-2) drives Toll-like receptor 4 (TLR4) liver inflammation in acute cholangitis, while its isoform MD-2B acts as a negative regulator. Targeting MD-2 may offer therapeutic benefits for liver injury.
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Acute cholangitis involves liver injury mediated by inflammatory responses.
- Toll-like receptor 4 (TLR4) signaling, involving myeloid differentiation protein-2 (MD-2), is implicated in inflammatory conditions.
- MD-2B is a known splicing isoform of MD-2 with potential inhibitory functions.
Purpose of the Study:
- To investigate the expression patterns of MD-2, MD-2B, and TLR4 in the liver during acute cholangitis in a rat model.
- To elucidate the roles of MD-2 and MD-2B in TLR4-mediated liver injury.
Main Methods:
- Male Sprague-Dawley rats were divided into sham-operated, bile duct ligation, acute cholangitis, and anti-TLR4 intervention groups.
- Liver tissue samples were analyzed for TLR4, MD-2, and MD-2B mRNA expression using fluorescence quantitative PCR.
- Pathological changes were assessed in parallel with molecular expression.
Main Results:
- Acute cholangitis led to increased TLR4 and MD-2 mRNA expression and decreased MD-2B mRNA expression over time.
- Anti-TLR4 antibody treatment reduced TLR4 and MD-2 mRNA levels while increasing MD-2B mRNA expression.
- MD-2 and TLR4 mRNA showed positive correlation, while MD-2B mRNA exhibited negative correlation with both MD-2 and TLR4.
Conclusions:
- MD-2 plays a significant role in promoting TLR4-mediated inflammatory liver injury during acute cholangitis.
- MD-2B acts as a negative regulator in this inflammatory process.
- These findings suggest potential therapeutic strategies targeting the MD-2/TLR4 pathway for acute cholangitis-induced liver injury.
